Literature DB >> 17284397

[Risk factors for eclampsia in Libreville (Gabon): a case-control study].

Sosthène Mayi-Tsonga1, Lambert Akouo, Jean-Pierre Ngou-Mve-Ngou, Jean-François Meye.   

Abstract

OBJECTIVES: To determine the current prevalence of eclampsia in our department, identify its risk factors and assess the prognosis of mother and child.
MATERIAL AND METHODS: This retrospective case-control study took place from January 1, 2004, through December 31, 2005, in the gynecology-obstetrics and intensive care departments of the Libreville Hospital Center. Every case of eclampsia was compared with three control patients. We collected social, demographic and clinical variables and compared them between the two groups. Univariate analysis was conducted with Epi Info 6.0. The odds ratio (OR) and 95% confidence intervals (95% CI) were calculated for each variable and compared with the Chi 2 test (significance defined as a p value less than 0.05).
RESULTS: The prevalence of eclampsia was 0.5%. The principal risk factors were: mother aged younger than 19 years (OR=3.38; CI= 1.77-6.47), nulliparity (2.21; 1.22-4.02) and one or no prenatal consultations (19.23; 6.45-61.40). Severe high blood pressure (>160/110 mmHg) was found in 52% of cases. There were 14 maternal deaths (21%) in the case group and none among the controls.
CONCLUSION: Improvement in the quality and quantity of prenatal care should help reduce the incidence of eclampsia.

Entities:  

Mesh:

Year:  2006        PMID: 17284397

Source DB:  PubMed          Journal:  Sante        ISSN: 1157-5999


  2 in total

1.  [Epidemiological profile and management of eclampsia in Senegal: about 62 cases].

Authors:  Abdoul Aziz Diouf; Moussa Diallo; Magatte Mbaye; Sokhna Diarra Sarr; Marie Edouard Faye-Diémé; Jean Charles Moreau; Alassane Diouf
Journal:  Pan Afr Med J       Date:  2013-11-06

2.  Rural and urban differences in blood pressure and pregnancy-induced hypertension among pregnant women in Ghana.

Authors:  Deborah van Middendorp; Augustinus ten Asbroek; Fred Yaw Bio; Anthony Edusei; Lyonne Meijjer; Sam Newton; Charles Agyemang
Journal:  Global Health       Date:  2013-11-14       Impact factor: 4.185

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.